Multiple myeloma patients get continued access to daratumumab in new safety study
NCT ID NCT05438043
First seen Jun 27, 2026 · Last updated Jul 31, 2026 · Updated 1 time
Summary
This study provides ongoing access to daratumumab-based treatment for 500 adults with multiple myeloma who are already benefiting from it in earlier Janssen trials. The main goal is to monitor long-term safety, including serious side effects and infections. Participants continue their current treatment regimen, which may include daratumumab alone or with other drugs like lenalidomide or carfilzomib.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Daratumumab (given alone or with carfilzomib, dexamethasone, lenalidomide, or pomalidomide)
- What this could lead to
- If successful, this study could confirm that long-term daratumumab treatment is safe and helps keep multiple myeloma under control for extended periods.
- What could go wrong
- This is an extension study, not a new treatment test. It does not aim to cure the disease, and participants must already be benefiting from daratumumab. Side effects like serious infections or infusion reactions remain possible.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Aarhus University Hospital
Aarhus N, DK-8200, Denmark
-
Alexandra General Hospital of Athens
Athens Attica, 115 28, Greece
-
Asklepios Klinik Altona
Hamburg, 22763, Germany
-
Barnes-jewish Hospital
St Louis, Missouri, 63108, United States
-
Baylor University Medical Center
Dallas, Texas, 75246, United States
-
Beijing Chaoyang Hospital
Beijing, 100020, China
-
CHU Nantes
Nantes, 44000, France
-
CNE Clinical Center of Oncology Hematology Transplantology and Palliative Care of the Cherkasy RC
Cherkasy, 18009, Ukraine
-
COI Clinicas Oncologicas Integradas
Rio de Janeiro, 22793 080, Brazil
-
Centre Hospitalier Universitaire (CHU) de Caen
Caen, 14033, France
-
Centro Integral Oncológico Clara Campal
Madrid, 28050, Spain
-
Chonnam National University Hwasun Hospital
Hwasun, 519-800, South Korea
-
City Hospital No.15
Saint Petersburg, 198205, Russia
-
Clinica Medica Sao Germano S/S LTDA
São Paulo, 04537-081, Brazil
-
Clinica Univ. de Navarra
Pamplona, 31008, Spain
-
Clinica Univ. de Navarra 1
Madrid, 28027, Spain
-
Clinical Research Institute of Hematology and Transfusiology
Saint Petersburg, 191024, Russia
-
Ege Universitesi Tip Fakultesi
Izmir, 35100, Turkey (Türkiye)
-
Emory University
Atlanta, Georgia, 30322, United States
-
Fakultni nemocnice Brno
Brno, 62500, Czechia
-
Fakultni nemocnice Plzen, Hemato-onkologicke oddeleni (Main)
Pilsen, 304 60, Czechia
-
First Affiliated Hospital Medical School of Zhejiang University
Hangzhou, 310020, China
-
First affiliated Hospital of Zhejiang University
Hangzhou, 310020, China
-
Fujian Medical University
Fuzhou, 350001, China
-
Guangdong General Hospital
Guangzhou, 510080, China
-
Henan Cancer Hospital
Zhengzhou, 450008, China
-
Hopital Haut Leveque
Pessac, 33604, France
-
Hopital Saint Louis
Paris, 75010, France
-
Hosp Clinic de Barcelona
Barcelona, 08036, Spain
-
Hosp Clinico Univ de Salamanca
Salamanca, 37007, Spain
-
Hosp. Del Mar
Barcelona, 08003, Spain
-
Hosp. Gral. Univ. Gregorio Maranon
Madrid, 28007, Spain
-
Hosp. Gral. Univ. J.M. Morales Meseguer
Murcia, 30008, Spain
-
Hosp. Mutua Terrassa
Terrassa, 08221, Spain
-
Hosp. Quiron Madrid Pozuelo
Pozuelo de Alarcón, 28223, Spain
-
Hosp. Univ. 12 de Octubre
Madrid, 28041, Spain
-
Hosp. Univ. Dr. Peset
Valencia, 46017, Spain
-
Hosp. Univ. Fundacion Alcorcon
Alcorcón, 28922, Spain
-
Hosp. Univ. Germans Trias I Pujol
Badalona, 08916, Spain
-
Hosp. Univ. Ramon Y Cajal
Madrid, 28034, Spain
-
Hosp. Univ. de Canarias
San Cristóbal de La Laguna, 38320, Spain
-
Icahn School of Medicine at Mount Sinai - The Derald H. Ruttenberg
New York, New York, 10029, United States
-
Inst. Cat. Doncologia-H Duran I Reynals
L'Hospitalet de Llobregat, 08908, Spain
-
Institute of Hematology and Blood Diseases Hospital
Tianjin, 300320, China
-
Klinikum Chemnitz gGmbH
Chemnitz, 09113, Germany
-
Leicester Royal Infirmary Haematology
Leicester, LE1 5WW, United Kingdom
-
Liga Norte Riograndense Contra O Cancer
Natal, 59062 000, Brazil
-
MNE Regional Oncology Center
Kharkiv, 61070, Ukraine
-
Memorial Sloan Kettering Cancer Center
New York, New York, 10065, United States
-
Ministerio da Saude Instituto Nacional do Cancer
Rio de Janeiro, 20230-130, Brazil
-
Municipal Non-Commercial Enterprise City Clinical Hospital No 4 of Dnipro City Council
Dnipro, 49102, Ukraine
-
Nanfang Hospital
Guangzhou, 510515, China
-
National Cancer Center
Goyang-si, 10408, South Korea
-
New Cross Hospital
Wolverhampton, WV10 0QP, United Kingdom
-
Nizhniy Novgorod Region Clinical Hospital
Nizhny Novgorod, 603126, Russia
-
Oncology Dispensary of Komi Republic
Syktyvkar, 167904, Russia
-
Peking Union Medical College Hospital
Beijing, 100006, China
-
Peking University First Hospital
Beijing, 100034, China
-
Peking University People's Hospital
Beijing, 100044, China
-
Pusan National University Hospital
Busan, 49241, South Korea
-
Real e Benemerita Associacao Portuguesa de Beneficencia
São Paulo, 01323 010, Brazil
-
Renji Hospital, Shanghai Jiaotong University School of Medicine
Shanghai, 200127, China
-
Republican Hospital named by V.A.Baranova
Petrozavodsk, 185019, Russia
-
Royal Marsden Hospital
Surrey, SM2 5PT, United Kingdom
-
Ruijin Hospital Shanghai Jiao Tong University
Shanghai, 200025, China
-
Ryazan Regional Clinical Hospital
Ryazan, 390003, Russia
-
S.P. Botkin Moscow City Clinical Hospital
Moscow, 125284, Russia
-
S.P. Botkin Moscow City Clinical Hospital 1
Moscow, 125284, Russia
-
Samsung Medical Center
Seoul, 06351, South Korea
-
Sapienza University of Rome
Roma, 00161, Italy
-
Saratov State Medical University
Saratov, 410012, Russia
-
Seoul National University Bundang Hospital
Seongnam, 13620, South Korea
-
Seoul National University Hospital
Seoul, 03080, South Korea
-
Shanghai Changzheng Hospital
Shanghai, 200003, China
-
St James University Hospital
Leeds, LS9 7TF, United Kingdom
-
The Catholic University of Korea Seoul St Marys Hospital
Seoul, 06591, South Korea
-
The First Affiliated Hospital of Soochow University
Suzhou, 215002, China
-
The First Affiliated Hospital of Wenzhou Medical University
Wenzhou, 325000, China
-
The First Bethune Hospital of Jilin University
Changchun, 130021, China
-
Tianjin cancer hospital
Tianjin, 300060, China
-
UNICAMP
Campinas, 13083-970, Brazil
-
Uniao Brasileira de Educacao e Assistencia Hospital Sao Lucas da PUCRS
Porto Alegre, 90610-000, Brazil
-
Universita Degli Studi di Roma Tor Vergata
Roma, 00133, Italy
-
Universitaetsklinikum Tuebingen der Eberhard-Karls-Universitaet, Abteilung fuer Innere Medizin II,
Tübingen, 72076, Germany
-
University of Miami Sylvester Cancer Center
Miami, Florida, 33136, United States
-
University of Michigan Comprehensive Cancer Center
Ann Arbor, Michigan, 48109, United States
-
Uniwersytecki Szpital Kliniczny w Poznaniu
Poznan, 60-569, Poland
-
Vinnytsya Regional Clinical Hospital named after M.I.Pirogov
Vinnitsa, 21018, Ukraine
-
Všeobecná fakultní nemocnice v
Prague, 128 08, Czechia
-
West China Hospital Si Chuan University
Chengdu, 610041, China
-
Wojewodzki Szpital Specjalistyczny w Legnicy
Legnica, 59-220, Poland
-
ZAS Cadix
Antwerp, 2030, Belgium
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could muscle loss predict blood cancer outcomes?
- Can a Triple-Action antibody deepen remissions in myeloma?
- Can a Low-Dose antifungal shield vulnerable patients from deadly fungal infections?
- Can a gentler chemo prep make stem cell transplants safer for blood cancer patients?
- Talking about the end: could guided conversations reduce futile cancer treatments?
- A guided path back to work after blood cancer: a trial tests the impact